The antiaging company is about to embark on a key test of its technology. New age for tech cash: Coinbase founder's ...

NewLimit has come up with a new anti-aging breakthrough by developing a drug that can reverse the aging in human cells.

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

Mesenchymal drift may help explain how cells lose stable identity and acquire pro-fibrotic, inflammatory mesenchymal traits ...

Fueled by multi-billion-dollar valuations and a deeper understanding of aging biology, the field is rapidly moving past the hype and into the clinic.

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating ...

Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called pro-aging metabolic reprogramming (PAMRP), which could change our ...

Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year ...

Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called Pro-Aging Metabolic Reprogramming (PAMRP), which could change our ...

A small study found that people taking semaglutide showed signs of slower biological aging compared with those taking a placebo.